140 related articles for article (PubMed ID: 24827508)
1. The effect of borneol on the concentration of meropenem in rat brain and blood.
Xin HL; He XR; Li W; Zhou ZD; Zhang S; Wang GJ
J Asian Nat Prod Res; 2014; 16(6):648-57. PubMed ID: 24827508
[TBL] [Abstract][Full Text] [Related]
2. Improved blood-brain barrier distribution: effect of borneol on the brain pharmacokinetics of kaempferol in rats by in vivo microdialysis sampling.
Zhang Q; Wu D; Wu J; Ou Y; Mu C; Han B; Zhang Q
J Ethnopharmacol; 2015 Mar; 162():270-7. PubMed ID: 25582491
[TBL] [Abstract][Full Text] [Related]
3. Determination and pharmacokinetic study of meropenem in rat bile using on-line microdialysis and liquid chromatography.
Chan YL; Chou MH; Lin MF; Chen CF; Tsai TH
J Chromatogr A; 2002 Jun; 961(1):119-24. PubMed ID: 12186382
[TBL] [Abstract][Full Text] [Related]
4. In vivo microdialysis with ultra performance liquid chromatography-mass spectrometry for analysis of tetramethylpyrazine and its interaction with borneol in rat brain and blood.
Liao W; Huang X; Yin Y; Liu B; Zhu R
Biomed Chromatogr; 2018 Jun; 32(6):e4210. PubMed ID: 29431191
[TBL] [Abstract][Full Text] [Related]
5. [Microdialysis and HPLC method for determination of concentration of pantoprazole in rat striatum aftercombined administration with borneol].
Wei Y; Liu P; He X; Chen Q
Zhongguo Zhong Yao Za Zhi; 2010 Oct; 35(19):2605-8. PubMed ID: 21174774
[TBL] [Abstract][Full Text] [Related]
6. Effect of Xiongbing compound on the pharmacokinetics and brain targeting of tetramethylpyrazine.
Wang LS; Shi ZF; Zhang YF; Guo Q; Huang YW; Zhou LL
J Pharm Pharmacol; 2012 Nov; 64(11):1688-94. PubMed ID: 23058057
[TBL] [Abstract][Full Text] [Related]
7. Population Pharmacokinetics and Target Attainment of Meropenem in Plasma and Tissue of Morbidly Obese Patients after Laparoscopic Intraperitoneal Surgery.
Wittau M; Scheele J; Kurlbaum M; Brockschmidt C; Wolf AM; Hemper E; Henne-Bruns D; Bulitta JB
Antimicrob Agents Chemother; 2015 Oct; 59(10):6241-7. PubMed ID: 26248353
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of Meropenem for Use in Bacterial Keratitis.
Sueke H; Kaye S; Wilkinson MC; Kennedy S; Kearns V; Zheng Y; Roberts P; Tuft S; Neal T
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5731-8. PubMed ID: 26325409
[TBL] [Abstract][Full Text] [Related]
9. The pharmacology of meropenem, a new carbapenem antibiotic.
Craig WA
Clin Infect Dis; 1997 Feb; 24 Suppl 2():S266-75. PubMed ID: 9126702
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic.
Harabe E; Kawai Y; Kanazawa K; Otsuki M; Nishino T
Drugs Exp Clin Res; 1992; 18(2):37-46. PubMed ID: 1644010
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of meropenem in critically ill patients with severe infections.
Binder L; Schwörer H; Hoppe S; Streit F; Neumann S; Beckmann A; Wachter R; Oellerich M; Walson PD
Ther Drug Monit; 2013 Feb; 35(1):63-70. PubMed ID: 23318279
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation.
Lodise TP; Nau R; Kinzig M; Drusano GL; Jones RN; Sörgel F
J Antimicrob Chemother; 2007 Nov; 60(5):1038-44. PubMed ID: 17785282
[TBL] [Abstract][Full Text] [Related]
13. Quantitative determination of unbound levofloxacin by simultaneous microdialysis in rat pancreas after intravenous and oral doses.
Liu D; Xu S; Xiao H; Wang Z; Mao N; Zhou J; Liu R; Huang Y
J Pharm Pharmacol; 2014 Sep; 66(9):1215-21. PubMed ID: 24961375
[TBL] [Abstract][Full Text] [Related]
14. [Borneol promotes oral absorption and penetration into brain of puerarin and catalpol].
Tang DD; Zhang J; Wang JR; Zhang JF; Xu XY
Zhongguo Zhong Yao Za Zhi; 2016 Jul; 41(14):2720-2726. PubMed ID: 28905612
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of meropenem determined by microdialysis in the peritoneal fluid of patients with severe peritonitis associated with septic shock.
Karjagin J; Lefeuvre S; Oselin K; Kipper K; Marchand S; Tikkerberi A; Starkopf J; Couet W; Sawchuk RJ
Clin Pharmacol Ther; 2008 Mar; 83(3):452-9. PubMed ID: 17687272
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy.
Thalhammer F; Hörl WH
Clin Pharmacokinet; 2000 Oct; 39(4):271-9. PubMed ID: 11069213
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of the opening of the blood-brain barrier by borneol: a pharmacodynamics and pharmacokinetics combination study.
Yu B; Ruan M; Dong X; Yu Y; Cheng H
J Ethnopharmacol; 2013 Dec; 150(3):1096-108. PubMed ID: 24432371
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of borneol and menthol in rats after oral administration of qingyan drop pills.
Xu X; Li Y; Hou J; Zhang S; Xu Y; Wang Y; Zhang Y; Liu C; He X
Planta Med; 2011 Sep; 77(14):1600-4. PubMed ID: 21484670
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Meropenem Penetration into Cerebrospinal Fluid in Patients with Meningitis After Neurosurgery.
Zhang Y; Zhang J; Chen Y; Yu J; Cao G; Wu X; Chen M; Wu J; Zhao X
World Neurosurg; 2017 Feb; 98():525-531. PubMed ID: 27867128
[TBL] [Abstract][Full Text] [Related]
20. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
Roberts JA; Kirkpatrick CM; Roberts MS; Robertson TA; Dalley AJ; Lipman J
J Antimicrob Chemother; 2009 Jul; 64(1):142-50. PubMed ID: 19398460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
